D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis

J Biol Chem. 1996 May 10;271(19):11209-13. doi: 10.1074/jbc.271.19.11209.

Abstract

Apoptosis (programmed cell death) is a fundamental process for normal development of multicellular organisms, and is involved in the regulation of the immune system, normal morphogenesis, and maintenance of homeostasis, ICE/CED-3 family cysteine proteases have been implicated directly in apoptosis, but relatively few of the substrates through which their action is mediated have been identified. Here we report that D4-GDI, an abundant hematopoietic cell GDP dissociation inhibitor for the Ras-related Rho family GTPases, is a substrate of the apoptosis protease CPP32/Yama/Apopain. D4-GDI was rapidly truncated to a 23-kDa fragment in Jurkat cells with kinetics that parallel the onset of apoptosis following Fas cross-linking with agonistic antibody or treatment with staurosporine. Fas- and staurosporine-induced apoptosis as well as cleavage of D4-GDI were inhibited by the ICE inhibitor, YVAD-cmk. D4-GDI was cleaved in vitro by recombinant CPP32 expressed in Escherichia coli to form a 23-kDa fragment. The CPP32-mediated cleavage of D4-GDI was completely inhibited by 1 microM DEVD-CHO, a reported selective inhibitor of CPP32. In contrast, the ICE-selective inhibitors, YVAD-CHO or YVAD-cmk, did not inhibit CPP32-mediated D4-GDI cleavage at concentrations up to 50 microM. N-terminal sequencing of the 23-kDa D4-GDI fragment demonstrated that D4-GDI was cleaved between Asp19 and Ser20 of the poly(ADP-ribose) polymerase-like cleavage sequence DELD19S. These data suggest that regulation by D4-GDI of Rho family GTPases may be disrupted during apoptosis by CPP32-mediated cleavage of the GDI protein.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alkaloids / pharmacology*
  • Amino Acid Sequence
  • Antibodies / pharmacology
  • Apoptosis* / drug effects
  • Caspase 3
  • Caspases*
  • Cell Line
  • Cysteine Endopeptidases / metabolism*
  • Cysteine Proteinase Inhibitors / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Enzyme Precursors / metabolism
  • GTP-Binding Proteins / metabolism*
  • Guanine Nucleotide Dissociation Inhibitors*
  • Humans
  • Kinetics
  • Molecular Sequence Data
  • Oligopeptides / pharmacology
  • Peptide Fragments / chemistry
  • Peptide Fragments / isolation & purification
  • Protein Kinase C / antagonists & inhibitors
  • Recombinant Proteins / metabolism
  • Staurosporine
  • Tumor Cells, Cultured
  • fas Receptor / immunology
  • fas Receptor / physiology*
  • rho Guanine Nucleotide Dissociation Inhibitor beta
  • rho-Specific Guanine Nucleotide Dissociation Inhibitors

Substances

  • ARHGDIB protein, human
  • Alkaloids
  • Antibodies
  • Cysteine Proteinase Inhibitors
  • Enzyme Inhibitors
  • Enzyme Precursors
  • Guanine Nucleotide Dissociation Inhibitors
  • Oligopeptides
  • Peptide Fragments
  • Recombinant Proteins
  • acetyl-aspartyl-glutamyl-valyl-aspartal
  • fas Receptor
  • rho Guanine Nucleotide Dissociation Inhibitor beta
  • rho-Specific Guanine Nucleotide Dissociation Inhibitors
  • Protein Kinase C
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Cysteine Endopeptidases
  • GTP-Binding Proteins
  • Staurosporine